Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 97

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

C-reactive protein is elevated in obese patients with the metabolic syndrome

Florez, Hermes, Castillo-Florez, Sumaya, Mendez, Armando, Casanova-Romero, Paul, Larreal-Urdaneta, Carmen, Lee, David, Goldberg, Ronald·2006·Diabetes Research and Clinical Practice
DOI 10.1016/j.diabres.2005.05.003
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2005.05.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 23

  1. Haffner, 1992, Prospective analysis of the Insulin-Resistance Syndrome (Syndrome X), Diabetes, 41, 715, 10.2337/diabetes.41.6.715 · DOI
  2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 85 (2001) 2486–2497. · DOI · Paper page
  3. Haverkate, 1997, Production of C-reactive protein and risk of coronary events in stable and unstable angina, Lancet, 349, 462, 10.1016/S0140-6736(96)07591-5 · DOI
  4. Koenig, 1999, C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men, Circulation, 99, 237, 10.1161/01.CIR.99.2.237 · DOI
  5. Mendall, 1996, C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study, BMJ, 321, 1061, 10.1136/bmj.312.7038.1061 · DOI
  6. Pickup, 1997, NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X, Diabetologia, 40, 1286, 10.1007/s001250050822 · DOI
  7. Fröhlich, 2000, Association between C-reactive protein and features of the metabolic syndrome: a population-based study, Diab. Care, 23, 1835, 10.2337/diacare.23.12.1835 · DOI · Paper page
  8. Festa, 2000, Chronic sub-clinical inflammation as part of the insulin resistance syndrome. The insulin resistance atherosclerosis study (IRAS), Circulation, 102, 42, 10.1161/01.CIR.102.1.42 · DOI
  9. Ridker, 2003, C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14719 initially healthy American women, Circulation, 107, 391, 10.1161/01.CIR.0000055014.62083.05 · DOI · Paper page
  10. Wu, 2002, Associations of serum C-reactive protein with fasting insulin, glucose, and glycosilated hemoglobin. The Third National Health and Nutrition Examination Survey, 1988–1944, Am. J. Epidemiol., 155, 65, 10.1093/aje/155.1.65 · DOI
  11. The Expert Committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diab. Care 26 (2003) 3160–3167. · DOI · Paper page
  12. Pearson, 2003, Workshop on Inflammatory Markers, and Cardiovascular Disease: application to clinical and public health practice. A statement for healthcare professionals from the Center for Disease Control and Prevention and the American Heart Association, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 · DOI · Paper page
  13. Ouchi, 2003, Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue, Circulation, 107, 671, 10.1161/01.CIR.0000055188.83694.B3 · DOI
  14. Danesh, 1999, Risk factors for coronary heart disease and acute-phase proteins: a population-based study, Eur. Heart J., 20, 954, 10.1053/euhj.1998.1309 · DOI
  15. Sakkinen, 2000, Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome, Am. J. Epidemiol., 152, 897, 10.1093/aje/152.10.897 · DOI
  16. Janssen, 2002, Body mass index, waist circumference and health risk, Arch. Intern. Med., 162, 2074, 10.1001/archinte.162.18.2074 · DOI
  17. St-Pierre, 2002, Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease, Am. J. Cardiol., 90, 15, 10.1016/S0002-9149(02)02378-0 · DOI
  18. Juhan-Vague, 1993, Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1,500 patients with angina pectoris, Arterioscler. Thromb., 13, 1865, 10.1161/01.ATV.13.12.1865 · DOI
  19. Barina-Mitchell, 2001, Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women, Am. J. Epidemiol., 153, 1094, 10.1093/aje/153.11.1094 · DOI
  20. Pradhan, 2001, C-reactive protein, interleukin-6, and risk of developing Type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327 · DOI · Paper page
  21. Han, 2002, Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study, Diab. Care, 25, 2016, 10.2337/diacare.25.11.2016 · DOI
  22. Freeman, 2002, C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study, Diabetes, 51, 1596, 10.2337/diabetes.51.5.1596 · DOI
  23. Ford, 1999, Body mass index, diabetes, and c-reactive protein among U.S. adults, Diab. Care, 22, 1971, 10.2337/diacare.22.12.1971 · DOI

Cited by

Metadata

Authors
Florez, H., Castillo-Florez, S., Mendez, A., Casanova-Romero, P., Larreal-Urdaneta, C., Lee, D., & Goldberg, R.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2006-01
Volume
71
Issue
1
Pages
92-100
ISSN
0168-8227
DOI
10.1016/j.diabres.2005.05.003
Cited by
97
References
6
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.